Navigate Up
Sign In


The module 1.4.1
Our passion is improving health. That is what keeps us at the forefront of scientific discovery and development.
The module 1.5.1

MSD is committed to improving the health and quality of life of Australians by developing innovative, high quality medicines. Working alongside our parent company, Merck & Co., Inc., Kenilworth, NJ, USA, we strive to stay at the forefront of discovery, undertaking research to find new and better ways of treating a broad range of conditions and diseases.

We are entering an exciting period with a strong product pipeline that targets a broad range of diseases. And we're looking ahead to the next generation of healthcare by using new techniques and technologies.

Therapeutic Areas

We focus our research on several key therapeutic areas, including:

  • Cardiovascular
  • Diabetes and Obesity
  • Bone, Respiratory, Immunology, and Dermatology
  • Infectious Disease
  • Oncology
  • Neurosciences and Ophthalmology
  • Women's Health and Endocrine
The module 1.5.2
The module 1.5.3
The module 1.5.1

The module 1.5.1

The module 1.4.3

In the Pipeline

From preclinical development to Phase III clinical trials, our passion for advancing health through science is evident in the breadth and depth of our pipeline.

The module 1.4.3 with Left image
The module 1.4.4
The module 1.4.7/1.4.8
The module 1.6.*

The module 1.6.*

The module 1.6.*

  • This site is intended for Australian residents. MSD is a member of Medicines Australia. MSD recommends patients always seek the medical advice of their healthcare professional.